Class II recall: American Regent, Inc.: niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a)
American Regent, Inc. issued a Class II recall of niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), supplied in 10 mL single dose vials and 10x10 mL single dose vial packs, manufactured for Civica, Inc. The recall notice states the product was contaminated with particulate matter identified as hair, glass, and/or paraformaldehyde.
Most relevant for: patients requiring nicardipine hydrochloride injection for acute hypertension management or acute coronary syndromes
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More cardiology updates
- OCEANIC-STROKE: Asundexian Not Linked to More Major BleedingOct 13, 2026
- ACC Statement Backs Whole-Food Diets Over Isolated NutrientsSep 30, 2026
- Oral GLP-1 drug orforglipron meets cardiovascular non-inferiority vs insulin glargineSep 30, 2026
- Stroke center status skews TAVR stroke rates in national registrySep 29, 2026
- Retatrutide produces substantial weight loss in phase 3 diabetes trialSep 29, 2026